Equillium, Inc.

EQ Nasdaq SEC CIK 1746466
Follow Equillium Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$4.6M −8.3% vs same quarter last year
EPS, diluted −$0.04 +33.3% vs same quarter last year
Operating cash flow −$3.8M +54.6% vs same quarter last year
Operating income −$5M −10.3% vs same quarter last year
Net income by quarter
−$5.8M
−$8.7M
−$5.7M
−$4.2M
−$3.8M
−$5.3M
−$4.7M
−$4.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income9 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50MFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25-−$22.4M
FY24$41.1M−$8.1M
FY23$36.1M−$13.3M
FY22$15.8M−$62.4M
FY21-−$39.1M
FY20-−$29.8M
FY19-−$25.6M
FY18-−$13.3M
FY17--
MarginsShare of revenue
  • Operating margin
  • Net margin
−400%−300%−200%−100%0%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24−20.1%−19.6%
FY23−40.2%−37%
FY22−393.9%−396.1%
FY21--
FY20--
FY19--
FY18--
FY17--
Free cash flowOperating cash flow minus capital expenditure
−$40M−$30M−$20M−$10M$0FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$22.8M
FY24−$19.1M
FY23−$21.8M
FY22−$9M
FY21−$32.1M
FY20−$24.8M
FY19−$23M
FY18−$7.6M
FY17-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Equillium
  • Healthcare median
−400%−300%−200%−100%0%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearEquilliumHealthcare median
FY25-−30.6%
FY24−19.6%−47%
FY23−37%−58%
FY22−396.1%−80.4%
FY21-−71.8%
FY20-−62.2%
FY19-−46.2%
FY18-−49.6%
FY17-−45.9%